Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | MGAM | O43451 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | SI | P14410 | 2/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16743578 | 0.97 | TSHR (0.43) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL129132 | 0.83 | MGAM (0.52) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL15949790 | 0.81 | TSHR (0.63) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL22667219 | 0.81 | MGAM (0.50) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL28412102 | 0.80 | TSHR (0.59) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL21453 | 0.80 | — | — | |
| SCHEMBL2030776 | 0.80 | GAA (0.50) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL11956800 | 0.79 | TSHR (0.46) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL12534515 | 0.79 | TSHR (0.46) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL4676685 | 0.79 | TSHR (0.46) | TSHRMGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023156764-A1 | PROCESS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2023-08-24 | — | — | WO | disclosed |
| US-20180171072-A1 | METHOD FOR MANUFACTURING A BRANCHED POLY(HYDROXYL ACID) | SOLVAY SA (BE) | 2018-06-21 | — | — | US | disclosed |
| US-20170338523-A1 | ACETIC ACID 2-[(METHOXYCARBONYL)OXY] METHYL ESTER AS ELECTROLYTE COMPONENT | BASF SE (DE) | 2017-11-23 | — | — | US | disclosed |
| US-9737605-B2 | Injectable controlled release composition comprising high viscosity liquid carrier | DURECT CORPORATION (US) | 2017-08-22 | — | — | US | disclosed |
| EP-2858971-B1 | HYDROCARBOXYLATION OF AQUEOUS FORMALDEHYDE USING A DEHYDRATING RECYCLE STREAM TO DECREASE WATER CONCENTRATION | EASTMAN CHEM CO (US) | 2016-04-06 | — | — | EP | disclosed |
| US-20160038596-A1 | INJECTABLE CONTROLLED RELEASE COMPOSITION COMPRISING HIGH VISCOSITY LIQUID CARRIER | DURECT CORPORATION (US) | 2016-02-11 | — | — | US | disclosed |
| US-9040748-B2 | Hydrocarboxylation of aqueous formaldehyde using a dehydrating recycle stream to decrease water concentration | EASTMAN CHEMICAL COMPANY (US) | 2015-05-26 | — | — | US | disclosed |
| US-9040748-B2 | Hydrocarboxylation of aqueous formaldehyde using a dehydrating recycle stream to decrease water concentration | EASTMAN CHEMICAL COMPANY (US) | 2015-05-26 | — | — | US | disclosed |
| US-20130030212-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130023693-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-20110009661-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| US-20110009661-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | IDEMITSU KOSAN CO., LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| WO-2009104753-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | 出光興産株式会社 (JP) | 2009-08-27 | — | — | WO | disclosed |
| US-5371001-A | Transesterification in the presence of carboxy-esterases or carboxyamidases | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-12-06 | — | — | US | disclosed |
| US-5326887-A | Reacting ester of alpha hydroxy acid oligomer over fixed bed catalyst | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-07-05 | — | — | US | disclosed |
| US-5254718-A | Using enzyme catalyst; simplified separation, purification | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1993-10-19 | — | — | US | disclosed |
| WO-1992015572-A1 | PROCESS FOR THE PREPARATION OF 1,4-DIOXANE-2,5-DIONES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-17 | — | — | WO | disclosed |
| WO-1992015547-A1 | ESTERS OF UNSYMMETRICALLY 2-SUBSTITUTED GLYCOLIC ACID DIMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030212-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | ALAD, MMAB, MAT1A | TSHR 2845/4885MGAM 1496/4885GAA 1805/4885 |
| US-20130023693-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | ALAD, MMAB, MAT1A | TSHR 2845/4885MGAM 1496/4885GAA 1805/4885 |
| US-20110009661-A1 | COMPOUND HAVING ALICYCLIC STRUCTURE, (METH)ACRYLIC ACID ESTER, AND PROCESS FOR PRODUCTION OF THE (METH)ACRYLIC ACID ESTER | ALAD, MMAB, MAT1A | TSHR 2845/4885MGAM 1496/4885GAA 1805/4885 |
| US-20160038596-A1 | INJECTABLE CONTROLLED RELEASE COMPOSITION COMPRISING HIGH VISCOSITY LIQUID CARRIER | HACD3, SAMM50, HACD2 | TSHR 2490/4885MGAM 51/4885GAA 707/4885 |
| US-20170338523-A1 | ACETIC ACID 2-[(METHOXYCARBONYL)OXY] METHYL ESTER AS ELECTROLYTE COMPONENT | ACMSD, HCN2, CA2 | TSHR 4678/4885MGAM 86/4885GAA 2739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.